※一部利用できない機能があります
Increased Level of Serum Vascular Endothelial Growth Factor by Long-Term Exposure to Hypergravity
- フォーマット:
- 論文
- 責任表示:
- Oshima, Masanobu ; Suzki, Hiromi ; Guo, Xiaoying ; Oshima, Hiroko
- 言語:
- 英語
- 出版情報:
- 日本実験動物学会 = Japanese Association for Laboratory Animal Science, 2007-01-01
- 著者名:
- 掲載情報:
- Experimental Animals
- ISSN:
- 1341-1357
- 巻:
- 56
- 通号:
- 4
- 開始ページ:
- 309
- 終了ページ:
- 313
- バージョン:
- publisher
- 概要:
- We have previously demonstrated that short-term exposure to hypergravity at 2G for 4 h induces expression of cyclooxygenase-2 (COX-2) in the mouse heart. Moreover, expression of vascular endothelial growth factor (VEGF) is also induced in the heart in a COX-2-dependent manner. Here, we demonstrate that long-term exposure of mice to 2G for 24 h resulted in a significant increase of serum VEGF level, although expression of COX-2 and VEGF in the heart decreased … to the 1G-control level. Moreover, increase of serum VEGF was not suppressed by treatment with COX-2 inhibitor, indicating that VEGF was induced in a COX-2-independent manner. These results suggest that gravitational force contributes to maintenance of the serum VEGF level. 続きを見る
- URL:
- http://hdl.handle.net/2297/28450
類似資料:
7
論文
Carcinogenesis in mouse stomach by simultaneous activation of the Wnt and PGE2 signaling pathways
金沢大学がん研究所 = Kanazawa University Cancer Research Institute | |
金沢大学がん研究所 = Kanazawa University Cancer Research Institute |
金沢大学がん研究所 = Kanazawa University Cancer Research Institute |
Japanese Cancer Association = 日本癌学会 |
American Society of Biochemistry and Molecular Biology, American Society for Biochemistry and Molecular Biology |
4
論文
The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models
Japanese Society of Gastroenterology 日本消化器病学会 / Springer |
金沢大学がん研究所 = Kanazawa University Cancer Research Institute |
Springer Japan | |
Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd / 日本病理学会 |
12
電子ブック
Comparative clinical and economic effectiveness of anti-vascular endothelial growth factor agents
Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service |